PofoliaShared via Pofolia

Cancer· 1973Q1

Carcinoma of the penis

Jean B. deKernion, Peter Tynberg, Lester Persky, J. Peter Fegen

Short summary

Prognosis for penile squamous carcinoma is strongly stage-dependent, with 3-year survivals ranging from 95% in Stage I to 0% in Stage IV (n=48).

AI-generated from the title and abstract; the full text is not read.

Key points

  • Three-year survival rates for penile squamous carcinoma vary significantly by stage: Stage I (95%), Stage II (67%), Stage III (29%), and Stage IV (0%) in 48 cases.
  • Partial penectomy was effective for primary lesions, with no local recurrences observed.
  • Clinical staging of inguinal node involvement was often inaccurate compared to histologic staging.
  • An aggressive approach to inguinal nodes is recommended to detect and treat occult metastases.

AI-generated from the title and abstract; the full text is not read.

Abstract

The prognosis of squamous carcinoma of the penis depends upon the stage of disease as determined by local invasion and involvement of inguinal nodes. Three-year survivals of 48 cases were: Stage I, 95%; Stage II, 67%; Stage III, 29%; and Stage IV, 0%. Most primary lesions were treated by partial penectomy, and no patient developed local recurrence. There was a significant discrepancy between initial clinical staging and histologic staging due to the difficulty in determining node metastases. In order to detect and eliminate occult metastases an aggressive approach to the inguinal nodes is proposed, including en bloc ileo-inguinal dissection for persistent clinical adenopathy, and routine superficial inguinal node biopsy of non-palpable nodes when the primary invades the corpora. The “skin bridge” technique of node dissection has some important advantages: the groin crease is not incised, and the blood supply to the flaps is preserved.

The authors' abstract, as published at the source. Cancer, 1973 · DOI ↗

TakeawaysPremium
Ask the paperFree account

Continue with a free account

Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.

Continue free on the web

Sign in with Google or Apple; no card needed. You come back to this paper.

On your phone:

Field: Surgery

SurgeryMedicine